Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Circulation

• Publication date

  2000-03-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.101.10.1130PMID 10715259
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants.

  1998cited by this paper
• Mitogen-activated protein kinase activation mediates PDGF-directed migration of RPE cells.

  1998cited by this paper
• Secretion of cardiac plasminogen activator during hypoxia-induced right ventricular hypertrophy.

  1997cited by this paper
• Myocardial osteopontin expression is associated with left ventricular hypertrophy.

  1997cited by this paper
• Increased gene expression of plasminogen activators and inhibitors in left ventricular hypertrophy

  1997cited by this paper
• Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts.

  1997cited by this paper
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

  1997cited by this paper
• Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium.

  1997cited by this paper
• AT1 and AT2 angiotensin receptor gene expression in human heart failure.

  1997cited by this paper
• Angiotensin II type 2 receptor mediates programmed cell death.

  1996cited by this paper
• The regulation of growth and intracellular signaling by integrins.

  1996cited by this paper
• Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction.

  1996cited by this paper
• Comparison of ANG II with other growth factors on Egr-1 and matrix gene expression in cardiac fibroblasts.

  1996cited by this paper
• Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase.

  1995cited by this paper
• Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts.

  1995cited by this paper
• GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction

  1994cited by this paper
• GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico.

  1994cited by this paper
• Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro.

  1994cited by this paper
• Human cardiac fibroblasts express an angiotensin receptor with unusual binding characteristics which is coupled to cellular proliferation.

  1994cited by this paper
• Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression.

  1994cited by this paper
• Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.

  1994cited by this paper
• Regulation of endothelin-1 mRNA by angiotensin II in rat heart endothelial cells.

  1993cited by this paper
• Identification of Functional Angiotensin II Receptors on Rat Cardiac Fibroblasts

  1993cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• Glomerular matrix accumulation is linked to inhibition of the plasmin protease system.

  1992cited by this paper
• Effect of growth factors on collagen metabolism in cultured human heart fibroblasts.

  1991cited by this paper
• Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during alpha-adrenergic stimulation of neonatal rat ventricular cells. Identification of cis sequences within an embryonic and a constitutive contractile protein gene which mediate inducible expression.

  1991cited by this paper
• Fibrillar Collagen and Myocardial Stiffness in the Intact Hypertrophied Rat Left Ventricle

  1989cited by this paper
• Angiotensin II receptors in normal and failing human hearts.

  1989cited by this paper
• Monoclonal antibodies to human prolyl 4-hydroxylase.

  1984cited by this paper
• Production of mRNA in Chinese hamster cells: relationship of the rate of synthesis to the cytoplasmic concentration of nine specific mRNA sequences.

  1979cited by this paper
• Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation

  1971cited by this paper

• Obesity-Associated Cardiac Fibrosis: Mechanisms and Emerging Therapeutic Targets

  2026cites this paper
• Cardio-Renal Syndrome: Review and New Perspectives

  2026cites this paper
• Angiotensin II Activates Yes-Associated Protein (YAP) in Fibroblast Promoting Deep Fascia Remodeling

  2025influential citation
• Angiotensin II-induced cardiac fibrosis and dysfunction are exacerbated by deletion of cGKI in periostin + myofibroblasts

  2025cites this paper
• Predicting cardiac and renal responses to sacubitril/valsartan with a mathematical model of heart failure with preserved ejection fraction.

  2025cites this paper
• Mutation of p53 Acetylation Protects Against Angiotensin-II-Induced Cardiac Dysfunction and Fibrosis

  2025cites this paper
• Systemic hemodynamics and pediatric lung disease: Mechanistic links and therapeutic relevance.

  2024cites this paper
• Defining Transcriptomic Heterogeneity between Left and Right Ventricle-Derived Cardiac Fibroblasts

  2024cites this paper
• BRD4 as a Therapeutic Target for Atrial Fibrosis and Atrial Fibrillation.

  2024cites this paper
• Non-invasive in vivo imaging of changes in Collagen III turnover in myocardial fibrosis

  2024cites this paper
• Mast Cells in Cardiac Remodeling: Focus on the Right Ventricle

  2024cites this paper
• The role of fibrosis in cardiomyopathies: an opportunity to develop novel biomarkers of disease activity.

  2024cites this paper
• Fibroblast and Immune Cell Cross-Talk in Cardiac Fibrosis

  2023cites this paper
• Cardiac RGS Proteins in Human Heart Failure and Atrial Fibrillation: Focus on RGS4

  2023cites this paper
• Dual Blockade of TGF-β Receptor and Endothelin Receptor Synergistically Inhibits Angiotensin II-Induced Myofibroblast Differentiation: Role of AT1R/Gαq-Mediated TGF-β1 and ET-1 Signaling

  2023influential citation
• Harnessing stem cell and lineage reprogramming technology to treat cardiac fibrosis

  2023cites this paper
• A novel caffeic acid derivative prevents angiotensin II-induced cardiac remodeling.

  2023cites this paper
• The therapeutic potential of targeting cardiac RGS4

  2023cites this paper
• Gαq protein-biased ligand of angiotensin II type 1 receptor mediates myofibroblast differentiation through TGF-β1/ERK axis in human cardiac fibroblasts.

  2023cites this paper
• Amygdalin and exercise training exert a synergistic effect in improving cardiac performance and ameliorating cardiac inflammation and fibrosis in a rat model of myocardial infarction.

  2023cites this paper
• Clinical Impact And Mechanisms Of Non-Atherosclerotic Vascular Aging: The New Kid to be Blocked.

  2023cites this paper
• Gβγ subunits co-localize with RNA polymerase II and regulate transcription in cardiac fibroblasts.

  2023cites this paper
• Molecular mechanisms of endothelial remodeling under doxorubicin treatment.

  2023cites this paper
• Blockage of the adenosine A2B receptor prevents cardiac fibroblasts overgrowth in rats with pulmonary arterial hypertension

  2023cites this paper
• MMP-2 and its implications on cardiac function and structure: interplay with inflammation in hypertension.

  2023cites this paper
• A novel therapeutic strategy for alleviating atrial remodeling by targeting exosomal miRNAs in atrial fibrillation.

  2022cites this paper
• Pathophysiology and pharmacology of G protein-coupled receptors in the heart.

  2022cites this paper
• Loureirin B Alleviates Myocardial Ischemia/Reperfusion Injury via Inhibiting PAI-1/TGF-β1/Smad Signaling Pathway

  2022cites this paper
• Proteomic Insights into Cardiac Fibrosis: From Pathophysiological Mechanisms to Therapeutic Opportunities

  2022cites this paper
• Exploring the cardiac ECM during fibrosis: A new era with next-gen proteomics

  2022cites this paper
• Evidence of Renin–Angiotensin System Receptors in Deep Fascia: A Role in Extracellular Matrix Remodeling and Fibrogenesis?

  2022cites this paper
• Uncoupling the Vicious Cycle of Mechanical Stress and Inflammation in Calcific Aortic Valve Disease

  2022cites this paper
• Sustained AT1R stimulation induces upregulation of growth factors in human cardiac fibroblasts via Gαq/TGF-β/ERK signaling that influences myocyte hypertrophy.

  2022cites this paper
• Cardiovascular GPCR regulation by regulator of G protein signaling proteins.

  2022cites this paper
• New Insights into the Functions of MicroRNAs in Cardiac Fibrosis: From Mechanisms to Therapeutic Strategies

  2022cites this paper
• Cardiac rehabilitation in heart failure with severely reduced ejection fraction: effects on mortality

  2022cites this paper
• The emerging role of leptin in obesity-associated cardiac fibrosis: evidence and mechanism

  2022cites this paper
• Subclinical Acute Kidney Injury in COVID-19: Possible Mechanisms and Future Perspectives

  2022cites this paper
• Class I HDAC modulates angiotensin II–induced fibroblast migration and mitochondrial overactivity

  2021cites this paper
• Cardiac fibrosis and curcumin: a novel perspective on this natural medicine

  2021cites this paper
• Lithium Reduces Migration and Collagen Synthesis Activity in Human Cardiac Fibroblasts by Inhibiting Store-Operated Ca2+ Entry

  2021cites this paper
• Fibrosis after Myocardial Infarction: An Overview on Cellular Processes, Molecular Pathways, Clinical Evaluation and Prognostic Value

  2021cites this paper
• Resveratrol and cardiac fibrosis prevention and treatment.

  2021cites this paper
• TGF-β: The missing link in obesity-associated airway diseases?

  2021cites this paper
• Leech extract: a candidate cardioprotective against hypertension-induced cardiac hypertrophy and fibrosis.

  2020cites this paper
• Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applications

  2020cites this paper
• Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis.

  2020cites this paper
• Clinical-pathological and immunohistochemical evaluations of cardiac lesions in cats with chronic kidney disease

  2020cites this paper
• Characterization of the Renin-Angiotensin System in Aged Cavernosal Tissue and its Role in Penile Fibrosis.

  2020cites this paper
• Inhibitory Effect of Valsartan on Pterygium Fibroblasts.

  2020cites this paper
• Transforming growth factor‐β signaling, a potential mechanism associated with diabetes mellitus and pancreatic cancer?

  2020cites this paper
• Mechanisms of Kidney and Heart Cross-talk in Acute Kidney Injury

  2020cites this paper
• Long non-coding RNA LICPAR regulates atrial fibrosis via TGF-β/Smad pathway in atrial fibrillation.

  2020cites this paper
• Tumor Microenvironment: Molecular Players – Part B

  2020cites this paper
• Renin-Angiotensin System in the Tumor Microenvironment.

  2020cites this paper
• Protective Effects of Olmesartan and L-carnitine on Doxorubicin-Induced Cardiotoxicity in Rats.

  2020cites this paper
• Thyroid, Heart Failure, and Neuroendocrine Activation

  2020cites this paper
• Functional cardiac fibroblasts derived from human pluripotent stem cells via second heart field progenitors

  2019cites this paper
• Alamandine attenuates long-term hypertension-induced cardiac fibrosis independent of blood pressure

  2019cites this paper
• Neurohormones, inflammatory mediators, and cardiovascular injury in the setting of heart failure

  2019cites this paper
• Adipose tissue-derived autotaxin causes cardiomyopathy in obese mice.

  2019cites this paper
• Alveolar type 2 progenitor cells for lung injury repair

  2019cites this paper
• MicroRNA-1-Mediated Inhibition of Cardiac Fibroblast Proliferation Through Targeting Cyclin D2 and CDK6

  2019cites this paper
• Irisin attenuates angiotensin II-induced cardiac fibrosis via Nrf2 mediated inhibition of ROS/ TGFβ1/Smad2/3 signaling axis.

  2019cites this paper
• Hirudin Protects Ang II-Induced Myocardial Fibroblasts Fibrosis by Inhibiting the Extracellular Signal-Regulated Kinase1/2 (ERK1/2) Pathway

  2018cites this paper
• Epac is required for exogenous and endogenous stimulation of adenosine A2B receptor for inhibition of angiotensin II-induced collagen synthesis and myofibroblast differentiation

  2018cites this paper
• Inhibitory Effects of Angiotensin II Receptor Blockade on Human Tenon Fibroblast Migration and Reactive Oxygen Species Production in Cell Culture

  2018cites this paper
• Myocardial Cell Signaling During the Transition to Heart Failure: Cellular Signaling and Therapeutic Approaches.

  2018cites this paper
• Fibroblast growth factor 23 is induced by an activated renin–angiotensin–aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts

  2018cites this paper
• Cardiac fibrosis: new insights into the pathogenesis

  2018cites this paper
• роль Left ventricular hypertrophy: renin4angiotensin system role

  2018cites this paper
• Basic Aspects of Cardiac Remodelling

  2018cites this paper
• ACE inhibition for severe bronchopulmonary dysplasia – an approach based on physiology

  2018cites this paper
• Study on Cardiotoxicity and Mechanism of “Fuzi” Extracts Based on Metabonomics

  2018cites this paper
• The Cardiokines: An Expanding Family of the Heart Secretome

  2017cites this paper
• Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways

  2017cites this paper
• Involvement of local renin‐angiotensin system in immunosuppression of tumor microenvironment

  2017cites this paper
• Special aspects of remodeling of the left ventricle in hypertensive disease

  2017cites this paper
• Characterization and Standardization of Cultured Cardiac Fibroblasts for Ex Vivo Models of Heart Fibrosis and Heart Ischemia

  2017cites this paper
• Investigating interactions between rat adult cardiac myocytes and fibroblasts in the heart

  2017cites this paper
• Genetic polymorphism of angiotensin-converting enzyme and hypertrophic cardiomyopathy risk

  2017cites this paper
• Valor pronóstico de los niveles de propéptido N-terminal del procolágeno tipos I y III asociados al remodelamiento ventricular en pacientes con insuficiencia cardiaca crónica

  2017cites this paper
• Diosgenin inhibits angiotensin II-induced extracellular matrix remodeling in cardiac fibroblasts through regulating the TGF‑β1/Smad3 signaling pathway.

  2017cites this paper
• Reduction in skeletal muscle fibrosis of spontaneously hypertensive rats after laceration by microRNA targeting angiotensin II receptor

  2017cites this paper
• Cardiorenal Syndrome Type 3

  2017cites this paper
• G-Protein-Coupled Receptors and Their Kinases in Cardiac Regulation

  2016cites this paper
• An Overview of Pharmacotherapy in Hypertrophic Cardiomyopathy: Current Speculations and Clinical Perspectives.

  2016cites this paper
• The Autonomic Cardiorenal Crosstalk: Pathophysiology and Implications for Heart Failure Management

  2016cites this paper
• Selection of a high-affinity and in vivo bioactive ssDNA aptamer against angiotensin II peptide.

  2016cites this paper
• Investigating Angiotensin II in cardiac remodelling and the counter-regulatory actions of Angiotensin-(1-9)

  2016cites this paper
• Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease.

  2016cites this paper
• Protective effect of Sheng-Mai Yin, a traditional Chinese preparation, against doxorubicin-induced cardiac toxicity in rats

  2016cites this paper
• Transcriptional regulation of ski and scleraxis in primary cardiac myofibroblasts

  2016cites this paper
• Autonomous and Non-autonomous Defects Underlie Hypertrophic Cardiomyopathy in BRAF-Mutant hiPSC-Derived Cardiomyocytes

  2016influential citation
• Extracellular nucleotide regulation and signaling in cardiac fibrosis.

  2016cites this paper
• The Role of β-adrenergic Signalling and Natriuretic Peptide Receptors in Cardiac Myofibroblast Proliferation and Differentiation

  2016cites this paper
• Angiotensin II as a morphogenic cytokine stimulating fibrogenesis of human tenon's capsule fibroblasts.

  2015cites this paper
• Cardiac Physiology of Aging: Extracellular Considerations.

  2015cites this paper
• Peptides of the renin angiotensin system and their potential roles in idiopathic pulmonary fibrosis

  2015cites this paper
• Outpatient management of chronic heart failure

  2015influential citation